Benefit-risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
Background: Sonidegib and vismodegib are Hedgehog pathway inhibitors (HhIs) that play a relevant role in the management of locally advanced basal cell carcinoma (laBCC). This study compared the efficacy and safety of both HhIs based on their available data using effect size measures such as number n...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
BioExcel Publishing Ltd,
2022-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|